Circulation:75岁以上老人也要运动!心血管疾病风险可明显降低

2015-11-22 QQduhq 译 MedSci原创

Mozaffarian说道:“虽然国家指导方针建议,老年人应进行有规律的体育活动,但很少有研究针对75岁以上的老年人进行,更无从得知他们的运动是否可降低心血管疾病的发病风险。我们的研究十分有意义,因为75岁老人这一群体的数目不断增加。我们的研究结果证实,75岁以上老人进行步行和休闲活动可降低心血管疾病的发病风险。”

在一个针对美国老年人进行的大型的、以社区为基础的研究中,研究结果表明,适度的体育锻炼可降低老人患心血管疾病(CVD)的风险。甚至对年龄超过75岁高龄的老人(这一年龄段的老人数目不断增长)都要适度进行运动锻炼,但这并没有足够的证据支持。 


塔夫茨大学弗里德曼营养科学Dariush Mozaffarian教授及其同事对一些平均年龄为73岁的老人进行研究,并在随后的十年时间里进行了详细的随访。在随访期间,研究人员收集老人的各种常规活动信息及老人对运动的评价与看法,并评估老人的身体状况随运动的变化。

研究人员对4207名男性和女性(CHS研究的参与者)进行了分析调查。并使用CHS数据库中关于老人锻炼,包括散步、休闲活动和运动强度,同时从病史、实验室评估、个人健康记录和风险因素评估等收集老人其他健康方面的信息。 

研究人员发现,若老人在散步和休闲活动时迈大步,则会明显降低他们患心血管疾病的风险。通过调整其他风险因素和生活方式后,研究显示,运动中迈大步可显著降低老人出现心脏病发作和中风的风险。 

相比步速小于2英里/小时(mph)的民众而言,步速超过3英里/小时(mph)的民众患冠心病(CHD)、中风和心血管疾病(CVD)的风险分别降低50%、53%、50%。 

平均每天快走超过7条街的民众患冠心病(CHD)、中风和心血管疾病(CVD)的风险比每周步行5条街的民众分别降低36%、54%和47%。 

进行休闲活动,如草坪修剪、园艺、游泳、骑自行车和徒步旅行的民众相比未进行这些活动的民众而言,患冠心病(CHD)、中风和心血管疾病(CVD)的风险也较低。男性和女性的研究结果相似。

Luisa Soares-Miranda博士说道:“我们的研究表明,即使民众处于晚年,都要进行适度的体力活动如散步等,这可明显降低他们出现心血管疾病的发生率,步行总距离增加或步伐加快都可降低心血管疾病风险。幸运的是,步行是许多老年人都可以进行和参与的低强度运动,他们都可以通过步行来降低心血管疾病的发病风险。” 

Mozaffarian说道:“虽然国家指导方针建议,老年人应进行有规律的体育活动,但很少有研究针对75岁以上的老年人进行,更无从得知他们的运动是否可降低心血管疾病的发病风险。我们的研究十分有意义,因为75岁老人这一群体的数目不断增加。我们的研究结果证实,75岁以上老人进行步行和休闲活动可降低心血管疾病的发病风险。”

原始出处:

Soares-Miranda L, Siscovick DS, Psaty BM, Longstreth WT Jr, Mozaffarian D.Physical Activity and Risk of Coronary Heart Disease and Stroke in Older Adults: The Cardiovascular Health Study.Circulation. 2015 Nov 4. 


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=94436, encodeId=5f729443605, content=好的,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 24 06:53:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55473, encodeId=0e08554e32b, content=运动益处多多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55474, encodeId=d781554e40c, content=赞,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55475, encodeId=71b6554e53e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47338, encodeId=e2c84e33842, content=运动, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Thu Dec 24 00:55:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472977, encodeId=2e3614e2977cf, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497934, encodeId=c82a149e93488, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=)]
    2016-07-24 午夜星河

    好的,谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=94436, encodeId=5f729443605, content=好的,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 24 06:53:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55473, encodeId=0e08554e32b, content=运动益处多多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55474, encodeId=d781554e40c, content=赞,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55475, encodeId=71b6554e53e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47338, encodeId=e2c84e33842, content=运动, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Thu Dec 24 00:55:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472977, encodeId=2e3614e2977cf, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497934, encodeId=c82a149e93488, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=)]
    2016-01-09 medsic

    运动益处多多!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=94436, encodeId=5f729443605, content=好的,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 24 06:53:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55473, encodeId=0e08554e32b, content=运动益处多多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55474, encodeId=d781554e40c, content=赞,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55475, encodeId=71b6554e53e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47338, encodeId=e2c84e33842, content=运动, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Thu Dec 24 00:55:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472977, encodeId=2e3614e2977cf, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497934, encodeId=c82a149e93488, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=)]
    2016-01-09 medsic

    赞,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=94436, encodeId=5f729443605, content=好的,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 24 06:53:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55473, encodeId=0e08554e32b, content=运动益处多多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55474, encodeId=d781554e40c, content=赞,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55475, encodeId=71b6554e53e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47338, encodeId=e2c84e33842, content=运动, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Thu Dec 24 00:55:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472977, encodeId=2e3614e2977cf, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497934, encodeId=c82a149e93488, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=)]
    2016-01-09 medsic

    谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=94436, encodeId=5f729443605, content=好的,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 24 06:53:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55473, encodeId=0e08554e32b, content=运动益处多多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55474, encodeId=d781554e40c, content=赞,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55475, encodeId=71b6554e53e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47338, encodeId=e2c84e33842, content=运动, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Thu Dec 24 00:55:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472977, encodeId=2e3614e2977cf, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497934, encodeId=c82a149e93488, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=)]
    2015-12-24 惜言

    运动

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=94436, encodeId=5f729443605, content=好的,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 24 06:53:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55473, encodeId=0e08554e32b, content=运动益处多多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55474, encodeId=d781554e40c, content=赞,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55475, encodeId=71b6554e53e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47338, encodeId=e2c84e33842, content=运动, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Thu Dec 24 00:55:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472977, encodeId=2e3614e2977cf, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497934, encodeId=c82a149e93488, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=94436, encodeId=5f729443605, content=好的,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200609/ef6a57dbe7f1489dad7446b7c5217858/d5e4fe65996c4446a029b0f5d056abb1.jpg, createdBy=6b011518214, createdName=午夜星河, createdTime=Sun Jul 24 06:53:00 CST 2016, time=2016-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55473, encodeId=0e08554e32b, content=运动益处多多!, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55474, encodeId=d781554e40c, content=赞,, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55475, encodeId=71b6554e53e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Sat Jan 09 23:55:00 CST 2016, time=2016-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=47338, encodeId=e2c84e33842, content=运动, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Thu Dec 24 00:55:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472977, encodeId=2e3614e2977cf, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497934, encodeId=c82a149e93488, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Nov 24 02:00:00 CST 2015, time=2015-11-24, status=1, ipAttribution=)]

相关资讯

儿童时期感染过传染性疾病=成年后早期心血管疾病风险大?

世界范围内,心血管疾病是健康的头号杀手,五分之四的死亡事件是由于心脏病发作及中风所致。近日,新的研究结果表明童年时期的感染或可增加心脏病的发病风险。

Eur J Prev Cardiol:吸烟加早产可使母亲患CVD的风险增加3倍

吸烟加早产可使母亲患CVD的风险增加3倍据发表于《欧洲预防心脏病学杂志》的一项新的研究表明,吸烟加早产可使母亲患CVD的风险增加3倍。 研究人员发现,吸烟和早产是CVD发病的两种独立危险因素,均可增加CVD的发病风险。吸烟且早产的妈妈发生CVD的风险为不吸烟且足月生产妈妈的3.35倍。“吸烟和早产可协同增加了母亲发生心血管疾病的风险,”Dr. Ngo说道。“当母亲吸烟且发生了早产时,则吸烟和早产可

J Bone Miner Res:膳食钙可降低老年人骨折、CVD、中风以及全因死亡的风险

J Bone Miner Res:膳食钙可降低老年人骨折、CVD、中风以及全因死亡的风险据发表于《骨与矿物质研究杂志》的一项研究表明,与摄入钙的水平最低的成年人相比,每天从食物中摄入1348 mg钙的老年人可降低其骨折、非致死性心血管疾病、中风以及全因死亡的风险。在一项以人群为基础的前瞻性队列研究中,研究人员分析了膳食钙的摄入与骨折、CVD以及全因死亡发生之间的关系。结果发现,尤其是那些无高血压病

AADE 2015:糖尿病护理的脂质准则

糖尿病护理的脂质准则所有协会所指定的脂质指南都奔着同一个目标——降低心血管疾病(CVD)的发病风险,但是在治疗靶点以及治疗措施上这些指南略有不同。AADE 2015,美国糖尿病教育协会的年度会议上,两名糖尿病专家探讨了这些指南,并讨论了如何更好的将这些指南整合到临床实践中。Evan Sisson博士及Dave Dixon博士表示,血脂异常的管理目前是基于:• 2013美国心脏病学会(ACC)/美国

Diabetes Care:CVD占糖尿病患者死因半壁江山(大庆研究23年随访结果)

北京阜外医院李光伟教授团队的最新研究表明,糖尿病与中国成人死亡率增加相关, CVD是主要死因,其中卒中引起的死亡几乎占半数。文章4月17日在线发表于《糖尿病护理》(Diabetes Care)杂志。研究者对比了1986年大庆研究中从110 660例受试者中筛选出来的新诊断为糖尿病者(NDD,630例)与正常糖耐量者(NGT,519例)的死亡率和死因,受试者年龄为25~74岁。结果显示,2

JACC:空腹甘油三酯可作为他汀治疗后CVD的预测指标

近期Gregory Schwartz博士研究团队完成了两个主要临床试验的数据析因分析。研究结果显示,对于服用他汀的急性冠脉综合征(ACS)患者,空腹甘油三酯水平升高与患者心血管事件风险率升高存在显著相关性,而且这种相关性在短期随访与长期随访过程中均得到了证实。研究论文发表于《美国心脏病学会杂志》。 研究者在此次研究中分析了MIRACL试验及dal-